AIDS

1. DIETERICH DT, Brunet L, Hsu RK, Mounzer K, et al
   Tenofovir interruption among people with HIV and HBV: HBV monitoring and risk of HBV reactivation and hepatitis flare.
   AIDS. 2025 Sep 19. doi: 10.1097/QAD.0000000000004353.
   

   >> Share

   
   

   
   Clin Infect Dis

2. MANN SC, Lykins D, Coyle RP, Witt MD, et al
   In the Mismatch: Viral Suppression Despite Low Tenofovir-Diphosphate in Dried Blood Spots in the Multicenter AIDS Cohort Study/Women's Interagency HIV Study Combined Cohort.
   Clin Infect Dis. 2025 Sep 17:ciaf509. doi: 10.1093.
   

   >> Share

   
   

   
   MMWR Morb Mortal Wkly Rep

3. PATEL RR, Hoover KW, Lale A, Cabrales J, et al
   Clinical Recommendation for the Use of Injectable Lenacapavir as HIV Preexposure Prophylaxis - United States, 2025.
   MMWR Morb Mortal Wkly Rep. 2025;74:541-549.
   

   >> Share

   
   

   
   PLoS One

4. SEQUERA-ARQUELLADAS S, Vivancos MJ, Vinuesa D, Collado A, et al
   Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trial.
   PLoS One. 2025;20:e0323167.
   

   >> Share

   
   
5. DEMISSIE AA, Rensburg EJV
   Healthcare providers' perspectives of barriers and facilitators to highly active antiretroviral therapy adherence among HIV-positive women in Southern Ethiopia: A qualitative study.
   PLoS One. 2025;20:e0312980.
   

   >> Share

   
   
6. WEN J, Ma X, Zhou X, Kissell RC, et al
   Molecular basis for the activation of the bitter taste receptor TAS2R14 by Ritonavir.
   PLoS One. 2025;20:e0332704.
   

   >> Share

   
   

   
   PLoS Pathog

7. CHOSHI P, Pedretti S, Chimbetete T, Gangula R, et al
   The association of class II HLA alleles with tuberculosis-associated immune reconstitution inflammatory syndrome.
   PLoS Pathog. 2025;21:e1013497.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share